This undiscovered pot stock has all the tools needed to succeed.
The U.S. Food and Drug Administration's harsh stance on cannabidiol should surprise no one.
Investing in marijuana stocks isn't as cut-and-dried as you might think.
These time-tested businesses are very close to joining an elite group of income stocks.
These are the only cannabis stocks with a billion-dollar valuation.
These adjustments could directly impact the wallets of program beneficiaries -- and even nonretirees -- next year.
Are these historically anti-cannabis states turning over a new leaf?
Despite mirroring the federal tax schedule on Social Security benefits as recently as 2016, these four states have made strides to become tax-friendly.
Despite being an industry leader, Canopy Growth's valuation should make investors cringe.
Growing federal debt obligations aren't a big deal for the most successful social program in history.
Despite robust growth prospects, investors have numerous reasons to be skeptical of cannabis stocks.
Ladenburg Thalmann sees more than 30% upside in three popular marijuana stocks.
If you think the broader stock market looks cheap, wait until you get a closer look at these two pot stocks.
Bank of America slashed its price target on this widely held cannabis stock by 20%.
It's probably a smaller amount than you would have expected.
With rumors of a white knight swirling, the following three cannabis stocks may make perfect suitors.
These income stocks look incredibly secure for a long time to come.
Derivative cannabis products will soon hit licensed Canadian dispensaries.
Rapid sales growth yields no guarantee of profitability in the cannabis space.
Bitcoin may be hot now, but the future for the world's largest cryptocurrency isn't so bright.